The Utility of Noninvasive serologic markers in the management of early allograft rejection in liver transplantation recipients

Transplantation

Volumn 68, Issue 2, 1999, Pages 247-253

  Dickson, Rolland C ^a,b   Lauwers, Gregory Y ^a   Rosen, Charles B ^c,d   Cantwell, Rachel ^f   Nelson, David R ^a   Lau, Johnson Y N ^a,e  

^a UNIVERSITY OF FLORIDA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ASSAY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE DUCTS; BILIRUBIN; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; GRAFT REJECTION; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; LIVER TRANSPLANTATION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0033609441     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907270-00015     Document Type: Article

References (13)

1. Wiesner RH, Goldstein RM, Donovan JP, Miller CM, Lake JR, Lucey MR. The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients. Liver Transplant Surg 1998; 4: 34.
2. International Working Party. Terminology for hepatic allograft rejection. Hepatology 1995; 22: 648.
3. Wiesner RH, Ludwig JL, Krom RAF, Hay JE, Van Hoek B. Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. Mayo Clinic Proc 1993; 68: 69.
4. Hiley C, Fryer A, Bell J, Hume R, Strange RC. The human glutathione S-transferases: immunohistochemical studies of the developmental expression of Alpha-and Pi-class isoenzymes in liver. Biochem J 1988; 254: 255.
5. Trull AK, Facey SP, Rees GW, et al. Serum a-glutathione S-transferase: a sensitive marker of hepatocellular damage associated with liver allograft rejection. Transplantation 1994; 58: 1345.
6. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
7. Vaubourdolle M, Chazouilleres O, Briaud I, et al. Plasma α-glutathione S-transferase as a marker of damage in patients with chronic hepatitis C. Gastroenterology 1994; 106: A1003.
8. Nelson DR, Lim HL, Oliver D, Qian KP, Davis GL, Lau JYN. α-Glutathione S-transferase: analysis of its utility in chronic hepatitis C virus infection. Am J Clin Pathol 1995; 104: 193.
9. McVicar JP, Kowdley KV, Bacchi CE, et al. The natural history of untreated focal allograft rejection in liver transplant recipients. Liver Transplant Surg 1996; 2: 154.
10. Neuberger J. Liver allograft rejection: current concepts on diagnosis and treatment. J Hepatol 1995; 23 (suppl 1): 54.
11. Nagral A, Butler P, Sabin CA, Rolles K, Burroughs AK. α-Glutathione-S-transferase in acute rejection of liver transplant recipients. Transplantation 1998; 65: 401.
12. Rosen HR, Martin P, Goss J, et al. Significance of early amino-transferase elevation after liver transplantation. Transplantation 1998; 65: 68.
13. Abraham SC, Furth EE. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology. Transplantation 1995; 59: 740.